fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹129.278 ↑ 0.10  (0.08 %) as on 20 Oct 20

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.2% since its launch.  Ranked 40 in Sectoral category.  Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

NAV as on 20 Oct 20₹129.278 ↑ 0.10  (0.08 %)
Net Assets (AUM) as on 30 Sep 2020 ₹586 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio7.99
Expense Ratio2.77 %
Sharpe Ratio1.792
Information Ratio0.39
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 20 Oct 20

DurationReturns
1 Month -2.5%
3 Month 18.3%
6 Month 32.4%
1 Year 64%
3 Year 15%
5 Year 4.7%
10 Year
15 Year
Since launch 14.2%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%

Growth of 10k Over Years

DateValue
30 Sep 15₹10,000
30 Sep 16₹9,340
30 Sep 17₹8,224
30 Sep 18₹8,901
30 Sep 19₹7,799
30 Sep 20₹12,984
UTI Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash4.42%
Equity95.58%
UTI Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care92.82%
Basic Materials2.76%
UTI Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
Drug Manufacturers - Specialty & Generic11%₹64 Cr124,140
↓ -8,667
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic11%₹62 Cr1,239,120
↓ -50,672
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic8%₹45 Cr148,420
↓ -29,385
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - General7%₹43 Cr559,275
↑ 47,090
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 524494
Drug Manufacturers - Specialty & Generic6%₹36 Cr164,427
↓ -24,102
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
Drug Manufacturers - Specialty & Generic6%₹34 Cr848,211
↑ 241,414
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic4%₹25 Cr309,240
↓ -21,904
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
Drug Manufacturers - Specialty & Generic4%₹24 Cr446,812
↓ -19,156
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
Biotechnology4%₹24 Cr533,700
↓ -12,684
Laurus Labs Ltd (Healthcare)
Equity, Since 30 Apr 20 | 540222
Drug Manufacturers - Specialty & Generic4%₹23 Cr786,180
↓ -365,340
1 - 10 of 25
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
V Srivatsa3 Mar 173.58 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹129.278
↑ 0.10
32.41 %64 %15.02 %4.73 %
UTI Healthcare Fund
Normal Dividend, Payout
₹99.9133
↑ 0.08
32.41 %64 %15.02 %4.73 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹99.9133
↑ 0.08
32.41 %64 %15.02 %4.73 %
Data as on 20 Oct 20

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.